The earnings call highlighted strong revenue and subscriber growth as well as expansion into new markets and healthcare offerings. However, there were notable challenges, including a decline in GLP-1 revenue, negative free cash flow, and increased G&A and tech costs.

Company Guidance -

Q3 2025

During the Hims & Hers Second Quarter 2025 Earnings Call, the company provided several key metrics and future guidance. The platform experienced significant growth, serving over 2.4 million subscribers at the end of the second quarter, with nearly 1.5 million receiving personalized treatment. Revenue increased by 73% year-over-year to $545 million, maintaining an adjusted EBITDA margin above 15%. The weight loss specialty, particularly the GLP-1 treatment plan, displayed strong retention with only 25% discontinuation after six months, compared to a typical 80% discontinuation rate within the same period in other studies. Looking ahead, the company anticipates achieving $725 million in revenue from its weight loss specialty by the end of the year and projects 2025 full-year revenue between $2.3 billion and $2.4 billion, with adjusted EBITDA ranging from $295 million to $335 million. Additionally, Hims & Hers aims to expand into new specialties and international markets, targeting $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030.

Record Revenue Growth

Revenue grew 73% year-over-year to $545 million, with an adjusted EBITDA margin of over 15% in Q2 2025.

Strong Subscriber Growth

Subscribers increased by 73,000 quarter-over-quarter to over 2.4 million, reflecting a year-over-year growth rate of 31%.

Expansion into New Markets

The acquisition of ZAVA expands Hims & Hers' presence in the U.K. and other European markets, with plans to enter Canada in 2026.

Innovative Healthcare Offerings

Launch of at-home lab testing and upcoming hormonal health specialty aims to broaden access to personalized healthcare solutions.

Hims & Hers Health (HIMS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

HIMS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	0.11 / -	0.32	―	―	―
Aug 04, 2025	2025 (Q2)	0.15 / 0.17	0.06	183.33% (+0.11)
May 05, 2025	2025 (Q1)	0.12 / 0.20	0.05	300.00% (+0.15)
Feb 24, 2025	2024 (Q4)	0.11 / 0.11	0.01	1000.00% (+0.10)
Nov 04, 2024	2024 (Q3)	0.11 / 0.32	-0.04	900.00% (+0.36)	―
Aug 05, 2024	2024 (Q2)	0.04 / 0.06	-0.03	300.00% (+0.09)	―
May 06, 2024	2024 (Q1)	0.01 / 0.05	-0.05	200.00% (+0.10)
Feb 26, 2024	2023 (Q4)	-0.02 / 0.01	-0.05	120.00% (+0.06)
Nov 06, 2023	2023 (Q3)	-0.04 / -0.04	-0.09	55.56% (+0.05)
Aug 07, 2023	2023 (Q2)	-0.05 / -0.03	-0.1	70.00% (+0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

HIMS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 04, 2025	$63.35	$55.52	-12.36%
May 05, 2025	$41.88	$49.47	+18.12%
Feb 24, 2025	$51.31	$39.86	-22.32%
Nov 04, 2024	$20.76	$20.64	-0.58%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.